NRXP
NRX Pharmaceuticals Inc
3.00$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -44.2% | -48.2% | +39.0% | -15.2% | -18.2% | +107.9% | -36.3% | +210.0% | -13.6% | -8.1% | +187.0% | |
| – | -47.4% | -51.4% | +45.8% | -15.9% | -19.6% | +119.7% | -36.7% | +160.3% | -25.6% | -17.2% | +296.1% | |
| – | -48.4% | -71.3% | +43.9% | -13.3% | -12.3% | +284.5% | -47.5% | +146.9% | +8.5% | -13.9% | +297.5% | |
| – | -48.4% | -71.3% | +43.9% | -13.3% | -12.3% | +284.5% | -47.5% | +146.9% | +8.5% | -13.9% | +297.5% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | -95.2% | +12.4% | +13.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +193.9% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | -47.9% | -5.0% | -5.3% | |
| – | -1.4% | -1.0% | +25.4% | -1.6% | +15.4% | +21.9% | +23.5% | +0.7% | -29.1% | -11.0% | +33.5% | |
| – | -1.4% | -1.0% | +25.4% | -14.2% | +7.7% | +49.8% | +23.5% | +0.3% | -29.6% | -11.9% | +34.5% | |
| – | -9.0% | -26.0% | +26.8% | -57.1% | -57.5% | +436.2% | +21.9% | +0.2% | -96.9% | +23.7% | +102.0% | |
| – | +27.6% | +35.3% | -20.0% | -3.0% | -15.1% | +4.4% | -15.8% | +17.3% | +0.3% | +3.0% | -28.5% | |
| – | – | – | – | – | +67.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +924.0% | -89.5% | +18.8% | +4.3% | -4.2% | +56.0% | +9.3% | +24.0% | +42.7% | +1.9% | +16.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.